查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1407330

藥用輔料市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品、功能、配方、地區和競爭細分

Pharmaceutical Excipients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Functionality, By Formulation, By Region and Compe
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年全球藥用輔料市場價值為 85.2 億美元，預計在預測期內將穩定成長，到 2028 年複合CAGR為5.25%。製藥業是一個充滿活力且不斷發展的行業，受到研究進步的推動，技術，以及對創新醫療解決方案不斷成長的需求。在這個錯綜複雜的領域中，藥用輔料作為惰性物質發揮著至關重要的作用，有助於活性藥物成分 (API) 的配製和輸送。全球藥用輔料市場經歷了顯著的成長和轉型，成為開發安全有效的藥品的重要組成部分。在研發活動增加的推動下，製藥業不斷擴大，是輔料市場的主要驅動力。隨著製藥公司努力將新型藥物製劑推向市場，對增強藥物穩定性、溶解度和生物利用度的賦形劑的需求顯著增加。

藥物傳遞領域的技術創新，包括緩釋製劑、標靶藥物傳遞系統和奈米技術，創造了對具有特定功能的賦形劑的需求。賦形劑在確保藥物精確地遞送至目標組織或器官、從而改善治療效果方面發揮關鍵作用。隨著對患者依從性和便利性的關注，開發患者友善劑型的趨勢日益明顯。賦形劑能夠配製口腔崩解片、液體製劑和其他以患者為中心的劑型，有助於提高藥物順從性。世界各地的監管機構都在強調藥品品質、安全性和功效的重要性。符合監管標準和指南的輔料擴大被採用，進一步推動市場發展。

主要市場促進因素

市場概況
預測期 2024-2028
2022 年市場規模 85.2億美元
2028 年市場規模 115.7億美元
2023-2028 年CAGR 5.25%
成長最快的細分市場 亞太地區
最大的市場 北美洲

對創新藥物製劑的需求不斷成長正在推動全球藥用輔料市場。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球藥用輔料市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品（有機化學物質、油脂化學物質（脂肪醇、金屬硬脂酸鹽、甘油等）、碳水化合物（糖、酒精、澱粉）、石化產品、蛋白質、磷酸鈣、金屬氧化物、石鹽、碳酸鈣、硫酸鈣等）
    • 按功能分類（填充劑和稀釋劑、懸浮劑和黏度劑、包衣劑、黏合劑、調味劑和甜味劑、崩解劑、著色劑、潤滑劑和助流劑、防腐劑、乳化劑等）
    • 按劑型（口服劑型、錠劑、膠囊劑（硬明膠膠囊、軟明膠膠囊）、液體劑型、外用劑型、腸外劑型、其他）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖
    • 按產品分類
    • 按功能分類
    • 按配方分類
    • 按地區

第 6 章：北美藥用輔料市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按功能分類
    • 按配方分類
    • 按國家/地區

第 7 章：歐洲藥用輔料市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按功能分類
    • 按配方分類
    • 按國家/地區

第 8 章：亞太地區藥用輔料市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按功能分類
    • 按配方分類
    • 按國家/地區

第 9 章：南美洲藥用輔料市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按功能分類
    • 按配方分類
    • 按國家/地區

第 10 章：中東和非洲藥用輔料市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按功能分類
    • 按配方分類
    • 按國家/地區

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 技術發布

第13章：競爭格局

  • 巴斯夫公司
    • Business Overview
    • Patient Offerings
    • Recent Developments
    • Key Personnel
    • SWOT Analysis
  • 歐利瑞儀器公司
  • 亞什蘭全球控股公司
  • 杜邦德內穆爾公司
  • 羅蓋特·費雷斯
  • 贏創工業股份公司
  • 英國聯合食品
  • 阿徹丹尼爾斯米德蘭公司
  • 路博潤公司
  • 禾大國際
  • 嘉里集團

第 14 章：策略建議

第 15 章：關於我們與免責聲明

簡介目錄
Product Code: 20063

Global Pharmaceutical Excipients Market has valued at USD 8.52 Billion in 2022 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2028. The pharmaceutical industry is a dynamic and ever-evolving sector, driven by advancements in research, technology, and an increasing demand for innovative healthcare solutions. Within this intricate landscape, pharmaceutical excipients play a crucial role as inert substances that aid in the formulation and delivery of active pharmaceutical ingredients (APIs). The global pharmaceutical excipients market has witnessed significant growth and transformation, becoming a vital component in the development of safe and effective pharmaceutical products. The expanding pharmaceutical industry, fueled by increased research and development activities, is a primary driver of the excipients market. As pharmaceutical companies strive to bring novel drug formulations to market, the demand for excipients that enhance drug stability, solubility, and bioavailability has risen significantly.

Technological innovations in drug delivery, including sustained-release formulations, targeted drug delivery systems, and nanotechnology, have created a demand for excipients with specific functionalities. Excipients play a pivotal role in ensuring the precise delivery of drugs to targeted tissues or organs, thereby improving therapeutic outcomes. With a focus on patient compliance and convenience, there is a growing trend toward the development of patient-friendly dosage forms. Excipients enable the formulation of orally disintegrating tablets, liquid formulations, and other patient-centric dosage forms, contributing to improved medication adherence. Regulatory bodies worldwide are emphasizing the importance of quality, safety, and efficacy in pharmaceutical products. Excipients that comply with regulatory standards and guidelines are witnessing increased adoption, driving the market further.

Key Market Drivers

Market Overview
Forecast Period2024-2028
Market Size 2022USD 8.52 Billion
Market Size 2028USD 11.57 Billion
CAGR 2023-20285.25%
Fastest Growing SegmentAsia Pacific
Largest MarketNorth America

Rising Demand for Innovative Drug Formulations is Driving the Global Pharmaceutical Excipients Market.

The global pharmaceutical industry is undergoing a transformative phase, driven by advancements in medical science and an increasing focus on patient-centric healthcare solutions. One of the key elements contributing to this evolution is the rising demand for innovative drug formulations. As pharmaceutical companies strive to develop more effective and patient-friendly medications, the role of pharmaceutical excipients has come into sharp focus. Pharmaceutical excipients are inactive substances that play a crucial role in drug formulation. While active pharmaceutical ingredients (APIs) are responsible for the therapeutic effects of a drug, excipients serve various functions, such as enhancing stability, improving bioavailability, and ensuring the proper release of the active ingredient. The pharmaceutical excipients market has witnessed significant growth in recent years, driven by the need for novel drug delivery systems and formulations that address the challenges of traditional drug development.

The pharmaceutical industry is increasingly moving toward novel drug delivery systems to enhance the efficacy and safety of medications. Excipients play a pivotal role in these systems, contributing to controlled-release formulations, targeted drug delivery, and improved bioavailability. Advanced technologies, such as nanotechnology and microencapsulation, rely heavily on specialized excipients to achieve precise drug delivery. The evolving healthcare landscape emphasizes patient-centric approaches, with a focus on personalized medicine. This shift has led to a growing demand for formulations that are easy to administer, have improved taste and texture, and ensure patient compliance. Excipients contribute to the development of patient-friendly dosage forms, such as orally disintegrating tablets, liquid formulations, and modified-release capsules.

Regulatory bodies worldwide are increasingly emphasizing the quality and safety of pharmaceutical products. Excipients, as crucial components of drug formulations, are subject to rigorous regulatory scrutiny. Manufacturers are compelled to adhere to strict quality standards, driving innovation in excipient development to meet regulatory requirements and ensure the safety and efficacy of pharmaceutical products. The rise of biopharmaceuticals and biosimilars has presented unique challenges in terms of formulation and stability. Excipients are vital in stabilizing these complex molecules, maintaining their structural integrity, and ensuring proper delivery. The growing market for biopharmaceuticals has consequently fueled the demand for excipients designed to meet the specific needs of these advanced therapeutic modalities. Pharmaceutical companies are investing heavily in research and development to discover new and more effective treatments. This includes the exploration of innovative excipients to overcome formulation challenges, improve drug performance, and optimize the overall drug development process.

Increasing Pharmaceutical R&D Investments is Driving the Global Pharmaceutical Excipients Market

The global pharmaceutical industry is experiencing a transformative phase driven by advancements in research and development (R&D). One significant contributor to this evolution is the growing focus on pharmaceutical excipients - the inert substances used as carriers or vehicles for active pharmaceutical ingredients (APIs). As pharmaceutical companies strive to enhance drug delivery systems and improve overall product efficacy, the demand for innovative excipients has surged. This surge is closely linked to the substantial increase in R&D investments across the pharmaceutical sector. Pharmaceutical research and development represent the cornerstone of medical progress. In recent years, there has been a notable uptick in R&D investments by pharmaceutical companies globally. Factors such as the need to address complex diseases, the pursuit of personalized medicine, and the exploration of novel therapeutic modalities have spurred an era of unprecedented innovation. One key driver of increased R&D spending is the rising prevalence of chronic diseases, necessitating the development of targeted and efficient drug delivery systems. Additionally, the global population is aging, leading to a growing demand for innovative pharmaceutical solutions that cater to the specific needs of elderly patients. As pharmaceutical companies aim to bring novel and effective drugs to market, the importance of excipients in optimizing drug formulations has become more evident.

Excipients play a crucial role in drug formulation by ensuring the stability, bioavailability, and controlled release of active pharmaceutical ingredients. They serve as essential components in various dosage forms, including tablets, capsules, injections, and topical formulations. Excipients contribute to the overall safety and effectiveness of pharmaceutical products, influencing factors such as drug solubility, absorption, and stability. In recent years, there has been a paradigm shift in the perception of excipients from mere inert substances to active contributors in drug development. Excipients are now recognized for their ability to enhance drug performance, improve patient compliance, and facilitate the development of specialized drug delivery systems.

The increasing emphasis on excipient innovation has propelled the global pharmaceutical excipients market to new heights. According to industry reports, the market is experiencing robust growth, with projections indicating sustained expansion in the coming years. The surge in pharmaceutical R&D investments has created a fertile ground for excipient manufacturers to develop and introduce cutting-edge products that meet the evolving needs of drug developers. Moreover, the pharmaceutical excipients market is witnessing a shift towards multifunctional excipients that can address multiple formulation challenges simultaneously. Excipients that enhance drug solubility, improve bioavailability, and enable controlled release are particularly in high demand. As pharmaceutical companies continue to explore biologics, personalized medicine, and other advanced therapeutic areas, the demand for specialized excipients tailored to these applications is expected to grow.

Key Market Challenges

Cost Pressures

The global pharmaceutical excipients market plays a pivotal role in the development and production of pharmaceutical formulations. Excipients, often overlooked by consumers, are crucial components that contribute to the stability, bioavailability, and overall efficacy of pharmaceutical products. While the industry is witnessing significant growth, it is not without its challenges. One of the most pressing issues is the relentless cost pressures that pharmaceutical excipient manufacturers face. The primary raw materials used in the production of pharmaceutical excipients include cellulose, starch, sugars, and polymers. Fluctuations in the prices of these raw materials can significantly impact production costs. External factors such as geopolitical events, climate change, and market dynamics can lead to unpredictable and sudden increases in raw material prices.

The pharmaceutical industry is heavily regulated, and excipient manufacturers must comply with strict quality standards and regulatory requirements. Achieving and maintaining compliance often involves substantial investments in research, development, and quality control processes, contributing to increased operational costs. The pharmaceutical industry is rapidly evolving, with continuous advancements in manufacturing technologies. While these innovations can lead to improved efficiency and product quality, they also necessitate substantial investments in equipment, training, and infrastructure, adding to the financial burden on manufacturers. Economic conditions, both globally and regionally, play a crucial role in shaping the cost landscape for pharmaceutical excipient manufacturers. Economic downturns, currency fluctuations, and geopolitical uncertainties can create an unpredictable business environment, making financial planning and cost containment challenging.

Key Market Trends

Technological Advancements

The global pharmaceutical industry is undergoing a transformative phase, driven by rapid technological advancements. One of the key beneficiaries of this progress is the pharmaceutical excipients market, which plays a crucial role in drug formulation and delivery. Pharmaceutical excipients are inert substances added to pharmaceutical formulations to enhance their stability, bioavailability, and overall efficacy. As technology continues to evolve, the pharmaceutical excipients market is experiencing significant growth, offering novel opportunities for innovation and efficiency. The formulation of pharmaceuticals has witnessed a paradigm shift with the integration of advanced technologies. Nanotechnology, for example, has opened new avenues for drug delivery systems. Nano-sized excipients enable improved solubility and targeted drug delivery, enhancing the overall therapeutic effect. This has led to the development of more effective and patient-friendly drug formulations. Moreover, the application of 3D printing technology in pharmaceuticals is gaining momentum. This technology allows for the precise deposition of pharmaceutical excipients and active ingredients layer by layer, facilitating the creation of personalized medicines with specific release profiles. The ability to customize drug formulations based on individual patient needs is a significant advancement that is reshaping the pharmaceutical landscape. Quality by Design (QbD) approaches, facilitated by advanced analytical tools and software, are becoming integral to the formulation process. QbD emphasizes the systematic development of pharmaceutical products to ensure quality and performance, thereby reducing the need for post-approval changes. This approach not only accelerates the drug development process but also enhances the reliability of pharmaceutical formulations.

Technological advancements have enabled the development of excipients that enhance drug stability and bioavailability. Excipients with controlled release properties help maintain optimal drug concentrations in the body, prolonging therapeutic effects and reducing the frequency of dosing. This is particularly crucial for patients with chronic conditions, improving treatment adherence and overall patient outcomes. Innovations in polymer science have led to the creation of biocompatible and biodegradable excipients that can be tailored for sustained-release formulations. These advancements contribute to the development of long-acting medications, offering patients the convenience of less frequent dosing while maintaining therapeutic efficacy.

The pharmaceutical excipients market is not only influenced by advancements in formulation technologies but also by innovations in digitalization and supply chain management. The integration of digital platforms and analytics tools helps streamline the production process, optimize resource allocation, and ensure consistent product quality. Real-time monitoring and data analytics enable manufacturers to identify and address potential issues in the production line promptly. This contributes to the overall efficiency of pharmaceutical excipient manufacturing, reducing waste and ensuring a reliable supply of high-quality excipients.

Segmental Insights

Product Insights

Based on the category of product, organic chemicals emerged as the dominant player in the global market for Pharmaceutical Excipients in 2022. Organic chemicals exhibit excellent compatibility with active pharmaceutical ingredients (APIs) and other excipients, making them suitable for a wide range of drug formulations. Their versatility allows formulators to address various challenges associated with the development of different types of drugs. Many organic chemicals possess surfactant properties, aiding in the solubilization of poorly water-soluble drugs. This is particularly crucial for enhancing the bioavailability of certain medications and ensuring their efficacy. The stability of pharmaceutical formulations is a critical consideration. Organic chemicals, such as antioxidants and stabilizers, play a key role in preventing degradation and ensuring the shelf life of drugs. Controlled release formulations have gained popularity for optimizing drug delivery and patient compliance. Organic chemicals can be tailored to achieve specific release profiles, allowing for sustained and controlled drug release.

Formulations Insights

The oral formulations segment is projected to experience rapid growth during the forecast period. Oral formulations are often preferred by patients due to their convenience and non-invasive nature. Unlike injections or intravenous medications, oral medications are easy to administer and do not require medical supervision. This factor significantly contributes to patient compliance, as individuals are more likely to adhere to prescribed treatments when they are delivered in a form that is familiar and easy to manage. The development of oral formulations has focused not only on efficacy but also on improving the overall patient experience. Innovations such as taste masking, easy-swallow coatings, and controlled-release technologies have been employed to enhance the palatability of oral medications. These advancements contribute to better patient acceptance and satisfaction, further solidifying the dominance of oral formulations.

Regional Insights

North America emerged as the dominant player in the global Pharmaceutical Excipients market in 2022, holding the largest market share in terms of value. North America boasts a robust pharmaceutical research and development landscape, with substantial investments in innovative drug formulations. This commitment to R&D extends to excipient development, leading to the creation of novel excipients that cater to the evolving needs of the pharmaceutical industry. The region's advanced technological infrastructure supports cutting-edge research and the development of sophisticated excipients. Technological advancements contribute to the creation of excipients with improved functionalities, such as controlled drug release mechanisms and enhanced solubility.

Key Market Players

BASF SE

Origin Instruments Corporation

Ashland Global Holdings

DuPont de Nemours, Inc.

Roquette Feres

Evonik Industries AG

Associated British Foods

Archer Daniels Midland Company

Lubrizol Corporation

Croda International

Kerry Group

Report Scope:

In this report, the Global Pharmaceutical Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Excipients Market, By Product:

  • Organic Chemicals
  • Oleochemicals
  • Carbohydrates
  • Petrochemicals
  • Proteins
  • Calcium Phosphate
  • Metal Oxides
  • Halites
  • Calcium Carbonate
  • Calcium Sulphate
  • Others

Pharmaceutical Excipients Market, By Functionality :

  • Fillers & Diluents
  • Suspending & Viscosity Agents
  • Coating Agents
  • Binders
  • Flavouring Agents & Sweeteners
  • Disintegrants
  • Colorants
  • Lubricants & Glidants
  • Preservatives Emulsifying Agents
  • Others

Pharmaceutical Excipients Market, By Formulations:

  • Oral Formulations
  • Tablets
  • Capsules
  • Liquid Formulations
  • Topical Formulations Parenteral Formulations
  • Other

Pharmaceutical Excipients Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Pharmaceutical Excipients Market.

Available Customizations:

  • Global Pharmaceutical Excipients market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Excipients Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Organic Chemicals, Oleochemicals(Fatty Alcohols, Metal Stearates, Glycerin, Other), Carbohydrates(Sugars, Alcohol, Starches), Petrochemicals, Proteins, Calcium Phosphate, Metal Oxides, Halites, Calcium Carbonate, Calcium Sulphate, Others)
    • 5.2.2. By Functionality (Fillers & Diluents, Suspending & Viscosity Agents, Coating Agents, Binders, Flavoring Agents & Sweeteners, Disintegrants, Colorants, Lubricants & Glidants, Preservatives, Emulsifying Agents, Others)
    • 5.2.3. By Formulation (Oral Formulations, Tablets, Capsules(Hard-gelatin Capsules, Soft-gelatin Capsules), Liquid Formulations, Topical Formulations, Parenteral Formulations, Other)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Functionality
    • 5.3.3. By Formulation
    • 5.3.4. By Region

6. North America Pharmaceutical Excipients Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Functionality
    • 6.2.3. By Formulation
    • 6.2.4. By Country
      • 6.2.4.1. United States Pharmaceutical Excipients Market Outlook
        • 6.2.4.1.1. Market Size & Forecast
        • 6.2.4.1.1.1. By Value
        • 6.2.4.1.2. Market Share & Forecast
        • 6.2.4.1.2.1. By Product
        • 6.2.4.1.2.2. By Functionality
        • 6.2.4.1.2.3. By Formulation
      • 6.2.4.2. Canada Pharmaceutical Excipients Market Outlook
        • 6.2.4.2.1. Market Size & Forecast
        • 6.2.4.2.1.1. By Value
        • 6.2.4.2.2. Market Share & Forecast
        • 6.2.4.2.2.1. By Product
        • 6.2.4.2.2.2. By Functionality
        • 6.2.4.2.2.3. By Formulation
      • 6.2.4.3. Mexico Pharmaceutical Excipients Market Outlook
        • 6.2.4.3.1. Market Size & Forecast
        • 6.2.4.3.1.1. By Value
        • 6.2.4.3.2. Market Share & Forecast
        • 6.2.4.3.2.1. By Product
        • 6.2.4.3.2.2. By Functionality
        • 6.2.4.3.2.3. By Formulation

7. Europe Pharmaceutical Excipients Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Functionality
    • 7.2.3. By Formulation
    • 7.2.4. By Country
      • 7.2.4.1. France Pharmaceutical Excipients Market Outlook
        • 7.2.4.1.1. Market Size & Forecast
        • 7.2.4.1.1.1. By Value
        • 7.2.4.1.2. Market Share & Forecast
        • 7.2.4.1.2.1. By Product
        • 7.2.4.1.2.2. By Functionality
        • 7.2.4.1.2.3. By Formulation
      • 7.2.4.2. Germany Pharmaceutical Excipients Market Outlook
        • 7.2.4.2.1. Market Size & Forecast
        • 7.2.4.2.1.1. By Value
        • 7.2.4.2.2. Market Share & Forecast
        • 7.2.4.2.2.1. By Product
        • 7.2.4.2.2.2. By Functionality
        • 7.2.4.2.2.3. By Formulation
      • 7.2.4.3. United Kingdom Pharmaceutical Excipients Market Outlook
        • 7.2.4.3.1. Market Size & Forecast
        • 7.2.4.3.1.1. By Value
        • 7.2.4.3.2. Market Share & Forecast
        • 7.2.4.3.2.1. By Product
        • 7.2.4.3.2.2. By Functionality
        • 7.2.4.3.2.3. By Formulation
      • 7.2.4.4. Italy Pharmaceutical Excipients Market Outlook
        • 7.2.4.4.1. Market Size & Forecast
        • 7.2.4.4.1.1. By Value
        • 7.2.4.4.2. Market Share & Forecast
        • 7.2.4.4.2.1. By Product
        • 7.2.4.4.2.2. By Functionality
        • 7.2.4.4.2.3. By Formulation
      • 7.2.4.5. Spain Pharmaceutical Excipients Market Outlook
        • 7.2.4.5.1. Market Size & Forecast
        • 7.2.4.5.1.1. By Value
        • 7.2.4.5.2. Market Share & Forecast
        • 7.2.4.5.2.1. By Product
        • 7.2.4.5.2.2. By Functionality
        • 7.2.4.5.2.3. By Formulation

8. Asia Pacific Pharmaceutical Excipients Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Functionality
    • 8.2.3. By Formulation
    • 8.2.4. By Country
      • 8.2.4.1. China Pharmaceutical Excipients Market Outlook
        • 8.2.4.1.1. Market Size & Forecast
        • 8.2.4.1.1.1. By Value
        • 8.2.4.1.2. Market Share & Forecast
        • 8.2.4.1.2.1. By Product
        • 8.2.4.1.2.2. By Functionality
        • 8.2.4.1.2.3. By Formulation
      • 8.2.4.2. India Pharmaceutical Excipients Market Outlook
        • 8.2.4.2.1. Market Size & Forecast
        • 8.2.4.2.1.1. By Value
        • 8.2.4.2.2. Market Share & Forecast
        • 8.2.4.2.2.1. By Product
        • 8.2.4.2.2.2. By Functionality
        • 8.2.4.2.2.3. By Formulation
      • 8.2.4.3. South Korea Pharmaceutical Excipients Market Outlook
        • 8.2.4.3.1. Market Size & Forecast
        • 8.2.4.3.1.1. By Value
        • 8.2.4.3.2. Market Share & Forecast
        • 8.2.4.3.2.1. By Product
        • 8.2.4.3.2.2. By Functionality
        • 8.2.4.3.2.3. By Formulation
      • 8.2.4.4. Japan Pharmaceutical Excipients Market Outlook
        • 8.2.4.4.1. Market Size & Forecast
        • 8.2.4.4.1.1. By Value
        • 8.2.4.4.2. Market Share & Forecast
        • 8.2.4.4.2.1. By Product
        • 8.2.4.4.2.2. By Functionality
        • 8.2.4.4.2.3. By Formulation
      • 8.2.4.5. Australia Pharmaceutical Excipients Market Outlook
        • 8.2.4.5.1. Market Size & Forecast
        • 8.2.4.5.1.1. By Value
        • 8.2.4.5.2. Market Share & Forecast
        • 8.2.4.5.2.1. By Product
        • 8.2.4.5.2.2. By Functionality
        • 8.2.4.5.2.3. By Formulation

9. South America Pharmaceutical Excipients Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Functionality
    • 9.2.3. By Formulation
    • 9.2.4. By Country
      • 9.2.4.1. Brazil Pharmaceutical Excipients Market Outlook
        • 9.2.4.1.1. Market Size & Forecast
        • 9.2.4.1.1.1. By Value
        • 9.2.4.1.2. Market Share & Forecast
        • 9.2.4.1.2.1. By Product
        • 9.2.4.1.2.2. By Functionality
        • 9.2.4.1.2.3. By Formulation
      • 9.2.4.2. Argentina Pharmaceutical Excipients Market Outlook
        • 9.2.4.2.1. Market Size & Forecast
        • 9.2.4.2.1.1. By Value
        • 9.2.4.2.2. Market Share & Forecast
        • 9.2.4.2.2.1. By Product
        • 9.2.4.2.2.2. By Functionality
        • 9.2.4.2.2.3. By Formulation
      • 9.2.4.3. Colombia Pharmaceutical Excipients Market Outlook
        • 9.2.4.3.1. Market Size & Forecast
        • 9.2.4.3.1.1. By Value
        • 9.2.4.3.2. Market Share & Forecast
        • 9.2.4.3.2.1. By Product
        • 9.2.4.3.2.2. By Functionality
        • 9.2.4.3.2.3. By Formulation

10. Middle East & Africa Pharmaceutical Excipients Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Functionality
    • 10.2.3. By Formulation
    • 10.2.4. By Country
      • 10.2.4.1. South Africa Pharmaceutical Excipients Market Outlook
        • 10.2.4.1.1. Market Size & Forecast
        • 10.2.4.1.1.1. By Value
        • 10.2.4.1.2. Market Share & Forecast
        • 10.2.4.1.2.1. By Product
        • 10.2.4.1.2.2. By Functionality
        • 10.2.4.1.2.3. By Formulation
      • 10.2.4.2. Saudi Arabia Pharmaceutical Excipients Market Outlook
        • 10.2.4.2.1. Market Size & Forecast
        • 10.2.4.2.1.1. By Value
        • 10.2.4.2.2. Market Share & Forecast
        • 10.2.4.2.2.1. By Product
        • 10.2.4.2.2.2. By Functionality
        • 10.2.4.2.2.3. By Formulation
      • 10.2.4.3. UAE Pharmaceutical Excipients Market Outlook
        • 10.2.4.3.1. Market Size & Forecast
        • 10.2.4.3.1.1. By Value
        • 10.2.4.3.2. Market Share & Forecast
        • 10.2.4.3.2.1. By Product
        • 10.2.4.3.2.2. By Functionality
        • 10.2.4.3.2.3. By Formulation

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Technology Launches

13. Competitive Landscape

  • 13.1. BASF SE
    • 13.1.1. Business Overview
    • 13.1.2. Patient Offerings
    • 13.1.3. Recent Developments
    • 13.1.4. Key Personnel
    • 13.1.5. SWOT Analysis
  • 13.2. Origin Instruments Corporation
  • 13.3. Ashland Global Holdings
  • 13.4. DuPont de Nemours, Inc.
  • 13.5. Roquette Feres
  • 13.6. Evonik Industries AG
  • 13.7. Associated British Foods
  • 13.8. Archer Daniels Midland Company
  • 13.9. Lubrizol Corporation
  • 13.10. Croda International
  • 13.11. Kerry Group

14. Strategic Recommendations

15. About us & Disclaimer